Neurophysiological effects of recombinant interferon-gamma and -alpha in man.
Treatment of malignant tumors with interferon (IFN) is in some patients accompanied by serious neurological side effects. The present study assessed neurophysiological changes in spontaneous EEG activity, visual-evoked cortical potentials (VEPs), and brainstem auditory-evoked potentials (BAEPs) during IFN-gamma or IFN-alpha therapy in 9 patients. In addition, blood pressure, heart rate and body temperature were monitored. In all sessions under IFN, the latency of the P100 component of the VEP was shortened as compared to baseline conditions. IFN also reduced latencies of BAEP components, and diminished amplitudes of the spontaneous EEG activity within the alpha and beta frequency band. These latter effects were somewhat less consistent than those on VEPs. The major neurophysiological changes appeared to be similar for IFN-gamma and IFN-alpha. The results are in accord with an excitatory effect of IFN on central nervous activity. The magnitude of changes excludes a neurotoxicity of IFN-gamma or IFN-alpha at the doses used in this study.
Born
J
J
Angewandte Physiologie, Universität Ulm, FRG.
Späth-Schwalbe
E
E
Pietrowsky
R
R
Porzsolt
F
F
Fehm
H L
HL
D000328:Adult; D000368:Aged; D001794:Blood Pressure; D001831:Body Temperature; D001921:Brain / Q000187:drug effects*; D001933:Brain Stem / Q000187:drug effects / Q000378:metabolism; D004569:Electroencephalography; D005072:Evoked Potentials, Auditory / Q000187:drug effects; D005074:Evoked Potentials, Visual / Q000187:drug effects; D005260:Female; D006339:Heart Rate; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects*; D007371:Interferon-gamma / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy; D011994:Recombinant Proteins
D007370:Interferon Type I; D011994:Recombinant Proteins; D007371:Interferon-gamma